Grail publishes presentation on diagnostic workups after positive multi-cancer blood tests
GRAL•Grail published a presentation on diagnostic workups after positive Galleri tests, reporting that cancer was identified in 150 of 285 patients (52.6%) within 360 days. Patients without identified cancer averaged 0.70 invasive procedures, compared with 1.25 among those with cancer.
1. Diagnostic workups
A retrospective claims analysis found cancer in 150 of 285 patients (52.6%) within 360 days of a positive Galleri multi-cancer early detection blood test. Patients without identified cancer averaged 0.70 invasive procedures, versus 1.25 among patients with cancer; imaging use averaged 1.17 and 1.25 procedures, respectively. The presentation said workups aligned with predicted cancer signal origins.
